Joko Widodo
Leading the pack was Island, securing a formidable $400 million in Series F financing for its enterprise browser technology. This Dallas-based cybersecurity firm, dedicated to enhancing secure digital operations for businesses, saw its valuation soar to an impressive $6.4 billion, a monumental leap more than double its 2024 valuation. The round was spearheaded by Evolution Equity Partners, a firm with a keen eye for high-growth cybersecurity ventures. Island’s innovative approach centers on transforming the web browser into a secure, controlled, and auditable workspace, offering unprecedented levels of data protection and operational efficiency. This substantial investment is expected to fuel the company’s global expansion, accelerate product development, and solidify its market leadership in the rapidly evolving enterprise security landscape, addressing the increasing need for robust defenses against sophisticated cyber threats in a hybrid work environment.
Close behind, and also commanding a $400 million investment, was Cyera, a New York-based powerhouse in enterprise data security. This Series G extension round, co-led by Evolution Equity Partners and Goldman Sachs Growth Equity, propelled Cyera’s total funding to an astounding $2.7 billion, according to Crunchbase data. Cyera specializes in providing comprehensive data security tools that not only govern human access and interaction but also extend to managing the security posture of AI agents, a critical and emerging frontier in data protection. The company’s platform offers deep visibility, classification, and protection for sensitive data across cloud environments, on-premise systems, and SaaS applications. This latest capital injection will enable Cyera to further innovate its AI-driven security capabilities, expand its research and development efforts, and scale its market reach to meet the escalating demand for proactive data security solutions in an increasingly complex and AI-integrated digital world.
Snorkel AI, based in San Francisco, secured $350 million in Series E funding, positioning itself at the forefront of foundational AI development. The round, co-led by prominent investors Insight Partners and S32, valued the seven-year-old company at an impressive $3.2 billion, highlighting its rapid ascent in the AI domain. Snorkel AI provides sophisticated tools and platforms that empower frontier labs and AI teams to develop specialized training data and environments, crucial for building and deploying high-performance AI models. The company boasts more than $375 million in annual recurring revenue, a testament to the strong demand for its solutions that streamline the data labeling, management, and model development lifecycle. This significant capital infusion will undoubtedly be channeled into accelerating platform enhancements, expanding its team of AI researchers and engineers, and broadening its reach within enterprises striving to harness the full potential of custom AI applications.
In the realm of health technology, Enveda Therapeutics, an AI-enabled drug discovery startup headquartered in Boulder, Colorado, successfully closed a $311 million Series E financing round. Catalio Capital Management led this substantial investment, joined by a diverse syndicate of new and existing investors. This latest funding brings Enveda’s total capital raised since its inception to more than $845 million, underscoring the enormous potential investors see in its innovative approach. Enveda leverages artificial intelligence and machine learning to rapidly identify and develop novel therapeutics from natural products, significantly de-risking and accelerating the drug discovery process. The funds are earmarked to advance its pipeline of drug candidates, expand its AI-driven discovery platform, and potentially initiate clinical trials for its most promising compounds, aiming to revolutionize how life-saving medicines are brought to market.
Precision Neuroscience, a New York-based startup at the cutting edge of neurotechnology, garnered $250 million in Series D funding. The round saw lead investments from Pershing Square and the Ackman Oxman Institute, signaling strong confidence in the company’s groundbreaking work. Precision Neuroscience is dedicated to developing advanced brain-computer interface (BCI) technology, with a particular focus on creating minimally invasive and highly precise neural implants. Their innovative approach aims to restore neurological function and improve the quality of life for individuals suffering from a wide range of neurological disorders. This substantial capital injection will be instrumental in accelerating the development and clinical testing of their BCI devices, expanding their research into complex brain functions, and scaling their operational capabilities to bring these transformative technologies closer to patients.
Venturing into wireless communications, Hubble Network, operating out of Seattle, secured $200 million in Series C funding. Smith Point Capital led this round, which set a valuation of $1.6 billion for the company. Hubble Network is pioneering a satellite network designed to extend connectivity to standard Bluetooth devices, offering a revolutionary solution for ubiquitous, low-power IoT communication. This technology has the potential to transform asset tracking, environmental monitoring, and remote sensing across vast geographical areas where traditional cellular or Wi-Fi networks are unavailable. The fresh capital will be utilized to further deploy its satellite constellation, enhance its ground infrastructure, and expand its service offerings to a global customer base, pushing the boundaries of what’s possible in interconnected devices.
Rightway, a New York-based provider of pharmacy benefits and care navigation services, raised $155 million in Series E funding, with Francisco Partners leading the investment. Rightway’s platform combines advanced technology with human guidance to simplify healthcare navigation and optimize pharmacy benefits for employees and their families. A key focus for the startup is the expansion of its AI capabilities, aiming to personalize care recommendations, streamline prescription management, and reduce healthcare costs for employers. This significant investment will accelerate the development of its AI-powered tools, broaden its service offerings, and expand its market presence, reinforcing its commitment to making healthcare more accessible, affordable, and effective.
Three companies tied for the eighth spot, each securing $100 million in funding, demonstrating the breadth of innovation attracting significant investment.
Rainmaker, an El Segundo, California-based startup, received $100 million in Series B funding for its ambitious work in cloud seeding and atmospheric research. This unique venture focuses on producing new freshwater resources through advanced meteorological techniques. Investments came from a notable syndicate including Noa, Upfront Ventures, DCVC, Lowercarbon Capital, and Dream Ventures, highlighting a growing investor interest in sustainable and climate-tech solutions. Rainmaker’s technology holds immense promise in addressing global water scarcity challenges by enhancing natural precipitation processes. The funds will be critical for scaling its cloud seeding operations, investing in further atmospheric research, and developing more efficient and environmentally sound methods for water generation.
Numeral, a San Francisco-based company, closed a $100 million Series C round led by Insight Partners for its AI-powered sales tax compliance platform. In an increasingly complex regulatory environment, Numeral offers businesses a streamlined and automated solution for managing sales tax obligations across multiple jurisdictions. Its AI capabilities ensure accuracy, reduce compliance risks, and free up valuable resources for businesses of all sizes. This investment will enable Numeral to further enhance its platform’s intelligence, expand its product features, and accelerate its market penetration, addressing a critical pain point for e-commerce and multi-state operations.
Finally, Micro1, also based in San Francisco, reportedly raised a fresh funding round exceeding $100 million, valuing the company at an impressive $4 billion, according to a Forbes article citing sources familiar with the deal. Micro1 is a pivotal player in the AI ecosystem, serving as a provider of high-quality AI training data to major AI labs. The demand for meticulously curated and labeled datasets is skyrocketing as AI models become more sophisticated and require vast amounts of diverse data for effective training. This substantial investment underscores the critical role of data infrastructure in the advancement of artificial intelligence. Micro1 will likely use these funds to expand its data collection and annotation capabilities, enhance its technological platform, and meet the escalating demands from leading AI research institutions and enterprises.
The methodology for this weekly roundup involved tracking the largest announced funding rounds within the Crunchbase database that were raised by U.S.-based companies for the period of September 19-25, 2026. While efforts are made to include all reported deals, a small time lag may occur for rounds announced late in the week. The collective investment in these top ten companies, totaling over $2.6 billion, paints a compelling picture of a venture capital market that remains bullish on innovation, particularly in sectors poised to redefine technology, healthcare, and sustainability. The continued influx of capital into cybersecurity, AI, and health not only validates the critical importance of these domains but also promises accelerated advancements and transformative impacts across industries in the coming years. Stay up to date with recent funding rounds, acquisitions, and more with the Crunchbase Daily.
